We are live on ! Find out more
BP

BBR Partners Portfolio holdings

AUM $1.79B
1-Year Est. Return 16.83%
This Fund
S&P 500
This Quarter Est. Return
+6.24%
1 Year Est. Return
+16.83%
3 Year Est. Return
+51.59%
5 Year Est. Return
+58.21%
10 Year Est. Return
+227.69%
AUM
$1.31B
AUM Growth
+$91.7M
Cap. Flow
+$21.9M
Cap. Flow %
1.67%
Top 10 Hldgs %
74.55%
Holding
254
New
34
Increased
37
Reduced
70
Closed
12

Sector Composition

Rank Sector Weight
1 Industrials 8.16%
2 Technology 7.11%
3 Financials 6.23%
4 Consumer Staples 3.64%
5 Healthcare 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEVA
226
Aeva Technologies
AEVA
$1.02B
$132K 0.01%
40,020
UBCP icon
227
United Bancorp
UBCP
$94.3M
$131K 0.01%
+10,000
New +$123K
CNDT icon
228
Conduent
CNDT
$230M
$121K 0.01%
+30,000
New +$110K
ENZ
229
DELISTED
Enzo Biochem, Inc.
ENZ
$112K 0.01%
+100,000
New +$112K
VMD icon
230
Viemed Healthcare
VMD
$451M
$110K 0.01%
+15,000
New +$107K
IONQ icon
231
IonQ
IONQ
$12.3B
$104K 0.01%
11,956
LFST icon
232
Lifestance Health
LFST
$4.16B
$90.1K 0.01%
12,873
HTZWW
233
Hertz Global Holdings Warrants
HTZWW
$74.7M
$89K 0.01%
40,649
+29,358
+260% +$71.6K
ALLO icon
234
Allogene Therapeutics
ALLO
$601M
$81.1K 0.01%
28,952
LOCL icon
235
Local Bounti
LOCL
$24.2M
$73.2K 0.01%
29,293
MRT icon
236
Marti Technologies
MRT
$176M
$69.3K 0.01%
35,000
ACRS icon
237
Aclaris Therapeutics
ACRS
$730M
$69K 0.01%
60,000
PRPL icon
238
Purple Innovation
PRPL
$33.2M
$23.7K ﹤0.01%
+960
New +$27.7K
OVID icon
239
Ovid Therapeutics
OVID
$435M
$14.7K ﹤0.01%
12,495
AEON icon
240
AEON Biopharma
AEON
$11.1M
$12.2K ﹤0.01%
+161
New +$14.2K
KYNB
241
Kyntra Bio
KYNB
$28.5M
$6.57K ﹤0.01%
658
TPHS
242
DELISTED
Trinity Place Holdings Inc.com
TPHS
$2.4K ﹤0.01%
+60,000
New +$6.98K
ALT icon
243
Altimmune
ALT
$539M
-374,784
Closed -$2.49M
ATMP icon
244
iPath Select MLP ETN
ATMP
$647M
-14,558
Closed -$365K
CORZZ icon
245
Core Scientific Inc Tranche 2 Warrants
CORZZ
$1.86B
-10,000
Closed -$86.9K
CP icon
246
Canadian Pacific Kansas City
CP
$82B
-2,718
Closed -$214K
DFIV icon
247
Dimensional International Value ETF
DFIV
$20.7B
-12,355
Closed -$444K
IEMG icon
248
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
-5,197
Closed -$278K
MURA
249
DELISTED
Mural Oncology
MURA
-10,000
Closed -$31.4K
REM icon
250
iShares Mortgage Real Estate ETF
REM
$542M
-25,000
Closed -$554K

Similar funds

BBR Partners's Q3 2024 Portfolio in Review

As of Q3 2024, BBR Partners held 254 positions worth $1.31B, up 7.5% from $1.22B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

BBR Partners's Q3 2024 filing shows 34 new, 37 increased, 70 reduced and 12 closed positions. Its largest new stake was Cisco: 21,766 shares worth $1.16M. The largest sale was Mid-America Apartment Communities, an estimated $3.23M.

By sector, the portfolio is most concentrated in Industrials at 8.2% of assets, down from 8.6% a quarter earlier, followed by Technology and Financials.

  • BBR Partners's largest Q3 2024 buy was Cisco: 21,766 shares worth $1.16M.
  • BBR Partners added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $10.3M increase.
  • BBR Partners's biggest Q3 2024 reduction was Mid-America Apartment Communities, cutting an estimated $3.23M.
  • BBR Partners fully exited Altimmune in Q3 2024, selling an estimated $2.49M.
  • BBR Partners's ten largest holdings make up 75% of its $1.31B portfolio in Q3 2024.
  • BBR Partners opened 34 new positions and closed 12 in Q3 2024.
  • BBR Partners's portfolio value rose 7.5% quarter-over-quarter to $1.31B.

Based on BBR Partners's 13F filing for Q3 2024, filed 13 Nov 2024.